Quest Diagnostics (DGX) Accumulated Expenses (2010 - 2025)

Quest Diagnostics has disclosed Accumulated Expenses across 14 years of filings, most recently posting $338.0 million for Q4 2025.

• Accumulated Expenses for Q4 2025 came in at $338.0 million, up 10.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $338.0 million (up 10.46% YoY), and the FY2025 annual result was $338.0 million, up 10.46% from the prior year.
• Accumulated Expenses came in at $338.0 million for Q4 2025 at Quest Diagnostics, up from $306.0 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $460.0 million in Q4 2021 to a low of $287.0 million in Q4 2023.
• The 5-year median for Accumulated Expenses is $338.0 million (2025), against an average of $356.6 million.
• Across the five-year window, Accumulated Expenses increased 29.21% in 2021 and slipped 26.79% in 2023, its largest moves.
• Quest Diagnostics' Accumulated Expenses stood at $460.0 million in 2021, then fell by 14.78% to $392.0 million in 2022, then slipped by 26.79% to $287.0 million in 2023, then grew by 6.62% to $306.0 million in 2024, then grew by 10.46% to $338.0 million in 2025.
• The last three Accumulated Expenses figures came in at $338.0 million (Q4 2025), $306.0 million (Q4 2024), and $287.0 million (Q4 2023), per Business Quant data.